Guardado en:
| Autores principales: | Makino, Kana, Makigusa, Natsumi, Kojima, Masahiro |
|---|---|
| Formato: | Preprint |
| Publicado: |
2025
|
| Materias: | |
| Acceso en línea: | https://arxiv.org/abs/2511.01290 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Model-robust Inference for Seamless II/III Trials with Covariate Adaptive Randomization
por: Yi, Kun, et al.
Publicado: (2025)
por: Yi, Kun, et al.
Publicado: (2025)
A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
por: Kojima, Masahiro, et al.
Publicado: (2025)
por: Kojima, Masahiro, et al.
Publicado: (2025)
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025)
por: Komaki, Moka, et al.
Publicado: (2025)
Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
por: Yamada, Kana, et al.
Publicado: (2026)
por: Yamada, Kana, et al.
Publicado: (2026)
Integrate Meta-analysis into Specific Study (InMASS) for Estimating Conditional Average Treatment Effect
por: Hanada, Keisuke, et al.
Publicado: (2025)
por: Hanada, Keisuke, et al.
Publicado: (2025)
Bayesian Parametric Methods for Deriving Distribution of Restricted Mean Survival Time
por: Hanada, Keisuke, et al.
Publicado: (2024)
por: Hanada, Keisuke, et al.
Publicado: (2024)
Random Effect Restricted Mean Survival Time Model
por: Hanada, Keisuke, et al.
Publicado: (2024)
por: Hanada, Keisuke, et al.
Publicado: (2024)
A General Form of Covariate Adjustment in Randomized Clinical Trials
por: Bannick, Marlena S., et al.
Publicado: (2023)
por: Bannick, Marlena S., et al.
Publicado: (2023)
A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
por: Sun, Hao, et al.
Publicado: (2025)
por: Sun, Hao, et al.
Publicado: (2025)
Covariate Balancing Based on Kernel Density Estimates for Controlled Experiments
por: Li, Yiou, et al.
Publicado: (2020)
por: Li, Yiou, et al.
Publicado: (2020)
A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
por: Zhang, Zhiwei, et al.
Publicado: (2025)
por: Zhang, Zhiwei, et al.
Publicado: (2025)
A Connection Between Covariate Adjustment and Stratified Randomization in Randomized Clinical Trials
por: Zhang, Zhiwei
Publicado: (2024)
por: Zhang, Zhiwei
Publicado: (2024)
A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
por: Li, Yuhan, et al.
Publicado: (2024)
por: Li, Yuhan, et al.
Publicado: (2024)
The Generalised Kernel Covariance Measure
por: Bergen, Luca, et al.
Publicado: (2026)
por: Bergen, Luca, et al.
Publicado: (2026)
The RobinCar Family: R Tools for Robust Covariate Adjustment in Randomized Clinical Trials
por: Bannick, Marlena, et al.
Publicado: (2026)
por: Bannick, Marlena, et al.
Publicado: (2026)
Optimal Correlation for Bernoulli Trials with Covariates
por: Morrison, Tim, et al.
Publicado: (2024)
por: Morrison, Tim, et al.
Publicado: (2024)
Toxicity Monitoring Rule for a Two-Cohort Phase II Clinical Trial with Bivariate Beta Prior
por: Wang, Yu, et al.
Publicado: (2026)
por: Wang, Yu, et al.
Publicado: (2026)
Sample size re-estimation in blinded hybrid-control design using inverse probability weighting
por: Kojima, Masahiro, et al.
Publicado: (2025)
por: Kojima, Masahiro, et al.
Publicado: (2025)
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
por: Zhu, Di, et al.
Publicado: (2026)
por: Zhu, Di, et al.
Publicado: (2026)
Estimating Bidirectional Causal Effects with Large Scale Online Kernel Learning
por: Tanaka, Masahiro
Publicado: (2025)
por: Tanaka, Masahiro
Publicado: (2025)
Risk-inclusive Contextual Bandits for Early Phase Clinical Trials
por: Kanrar, Rohit, et al.
Publicado: (2025)
por: Kanrar, Rohit, et al.
Publicado: (2025)
Nonstationary Spatial Process Models with Spatially Varying Covariance Kernels
por: Coube-Sisqueille, Sébastien, et al.
Publicado: (2022)
por: Coube-Sisqueille, Sébastien, et al.
Publicado: (2022)
TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
por: Sun, Hao, et al.
Publicado: (2025)
por: Sun, Hao, et al.
Publicado: (2025)
Robust Covariate Adjustment in Multi-Center Randomized Trials
por: Alene, Muluneh, et al.
Publicado: (2025)
por: Alene, Muluneh, et al.
Publicado: (2025)
Selective Information Borrowing for Region-Specific Treatment Effect Inference under Covariate Mismatch in Multi-Regional Clinical Trials
por: Li, Chenxi, et al.
Publicado: (2026)
por: Li, Chenxi, et al.
Publicado: (2026)
Robust Local Polynomial Regression with Similarity Kernels
por: Shulman, Yaniv
Publicado: (2025)
por: Shulman, Yaniv
Publicado: (2025)
Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
por: Hall, Andrew, et al.
Publicado: (2025)
por: Hall, Andrew, et al.
Publicado: (2025)
COADVISE: Covariate Adjustment with Variable Selection in Randomized Controlled Trials
por: Liu, Yi, et al.
Publicado: (2025)
por: Liu, Yi, et al.
Publicado: (2025)
Stratification in Randomised Clinical Trials for Rare Diseases and Analysis of Covariance: Some Simple Theory and Recommendations
por: Senn, Stephen, et al.
Publicado: (2024)
por: Senn, Stephen, et al.
Publicado: (2024)
Semi-Supervised Treatment Effect Estimation with Unlabeled Covariates for Prediction-Powered Causal Inference
por: Kato, Masahiro
Publicado: (2025)
por: Kato, Masahiro
Publicado: (2025)
Covariate Balancing and Riesz Regression Should Be Guided by the Neyman Orthogonal Score in Debiased Machine Learning
por: Kato, Masahiro
Publicado: (2026)
por: Kato, Masahiro
Publicado: (2026)
An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
por: Zehetmayer, Sonja, et al.
Publicado: (2026)
por: Zehetmayer, Sonja, et al.
Publicado: (2026)
Double Debiased Covariate Shift Adaptation Robust to Density-Ratio Estimation
por: Kato, Masahiro, et al.
Publicado: (2023)
por: Kato, Masahiro, et al.
Publicado: (2023)
Covariate Adjustment for the Win Odds: Application to Cardiovascular Outcomes Trials
por: Scheidegger, Cyrill, et al.
Publicado: (2025)
por: Scheidegger, Cyrill, et al.
Publicado: (2025)
Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
por: Jobson, Deddy, et al.
Publicado: (2024)
por: Jobson, Deddy, et al.
Publicado: (2024)
A Two-Step Test to Identify Zero-Inflated Biomarkers in Early-Phase Clinical Trials
por: Xi, Nan Miles, et al.
Publicado: (2025)
por: Xi, Nan Miles, et al.
Publicado: (2025)
Active Adaptive Experimental Design for Treatment Effect Estimation with Covariate Choices
por: Kato, Masahiro, et al.
Publicado: (2024)
por: Kato, Masahiro, et al.
Publicado: (2024)
Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
por: Wang, Sidi, et al.
Publicado: (2026)
por: Wang, Sidi, et al.
Publicado: (2026)
A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
por: Zhan, Tianyu
Publicado: (2023)
por: Zhan, Tianyu
Publicado: (2023)
Optimal Functional Bilinear Regression with Two-way Functional Covariates via Reproducing Kernel Hilbert Space
por: Yang, Dan, et al.
Publicado: (2023)
por: Yang, Dan, et al.
Publicado: (2023)
Ejemplares similares
-
Model-robust Inference for Seamless II/III Trials with Covariate Adaptive Randomization
por: Yi, Kun, et al.
Publicado: (2025) -
A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
por: Kojima, Masahiro, et al.
Publicado: (2025) -
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025) -
Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
por: Yamada, Kana, et al.
Publicado: (2026) -
Integrate Meta-analysis into Specific Study (InMASS) for Estimating Conditional Average Treatment Effect
por: Hanada, Keisuke, et al.
Publicado: (2025)